A new editorial paper was published in Oncotarget titled "Unveiling the non-canonical functions of EZH2 in prostate cancer." Prostate cancer (PCa) is ranked as the second leading cause of ...

The proapoptotic protein, prostate apoptosis response-4 (Par-4), acts as a tumor suppressor in prostate cancer cells. The serine/threonine kinase casein kinase 2 (CK2) has a well-reported role in ...

Many men who have aggressive but localized prostate cancer have to have a radical prostatectomy (RP), where the whole of the prostate gland is removed with the surrounding structures. The treatment ...

Among patients with prostate cancer who received MRI-guided stereotactic body radiation therapy (SABR), more than 80% demonstrated “classic” neurovascular bundle patterns and over 96% showed more than ...

Treatment with the recently approved, minimally invasive Optilume BPH device improves urinary symptoms while preserving sexual function in men with benign prostatic hyperplasia (BPH), concludes a ...

John P. Mulhall, MD John P. Mulhall, MD, director of the Male Sexual and Reproductive Medicine Program at Memorial Sloan-Kettering Cancer Center in New York City, has written a new book titled Saving ...

Early detection and management of prostate cancer has improved the chances of survival in many patients. Erectile dysfunction (ED) is a common side effect in men receiving prostate cancer treatment, ...